COMPASS RECOVERY OPIOID REHABILITATION PROGRAM QUESTIONAIRE FOR PROSPECTIVE OPIOID REHABILITATION. Name Birthdate / /
|
|
- Kevin Evans
- 5 years ago
- Views:
Transcription
1 COMPASS RECOVERY OPIOID REHABILITATION PROGRAM QUESTIONAIRE FOR PROSPECTIVE OPIOID REHABILITATION Name Birthdate / / Home phone ( ) - Cell phone ( ) - Please answer the following questions which will help us to design your plan of treatment: Why are you interested in our rehabilitation program? Have you been previously treated with Suboxone? yes no When/Where was your last treatment? How long were you treated? Is there any problem that makes it difficult for you to give routine urine specimens? yes no If yes, please explain History: Please list all drugs you have used in the past: Have you ever injected IV drugs? If yes, have you ever shared needles? Have you ever been tested for HIV/AIDS? yes no yes no yes no If yes, what was the date of your last test? Result? Neg Pos Have you ever been tested for Hepatitis B or C? If yes, are you being treated for Hepatitis B or C? yes no yes no Have you ever been treated for substance dependence or misuse (e.g., detoxification program)? yes no If yes, please describe setting, length Have you ever overdosed on alcohol or drugs? yes no Have you ever been treated by a psychiatrist? yes no (Please describe treatment reason, setting, and length) Have you ever been suicidal? yes no Have you ever been homicidal? yes no 1
2 Current: Please list the drugs you use and when your last use was: Drug: Last used: Drug: Last used: Drug: Last used: Drug: Last used: Are these drugs prescribed, bought on the street, or both? Drinking Pattern: Daily Periodic Binge Weekend only Amount typically consumed (#of drinks)? Type of Alcohol (check all that apply): Beer Wine Liquor Are you currently taking Xanax, Valium, Klonopin, Ambien or any benzodiazepine? yes no If so, which one(s) and how much? Are you willing to taper off of the benzodiazepine listed above? yes no Have you ever had a seizure from alcohol or benzo withdrawal? yes no Are you willing to stop drinking alcohol? yes no Are you willing to stop smoking marijuana? yes no Have you ever had DT s? yes no Do you have any current or past legal issues that have resulted from your addiction? yes no If yes, explain Are you currently employed? yes no How many hours/week (avg.)? What caused you to start using opiates originally? Have you ever tried to quit on your own? yes no Please describe? What are the major sources of stress in your life? 2
3 What are your major strengths to deal with the stress in your life? What coping methods have you developed to deal with triggers to relapse? What benefit do you expect from Suboxone? Please describe your current living arrangements: Does anyone in your family (mother, father, brother/sister, child, aunt/uncle or grandparent) have a current or past history of substance abuse? yes no If yes, please list who and what substance: Do you have any medical conditions (diabetes, heart disease, hepatitis, HIV+, epilepsy, STDs, etc.)? yes no If yes, please explain Are you currently taking any medications to treat these conditions? yes no (List medication and dosage) Are you pregnant? ( ) N/A ( ) N ( ) Y ( ) Not Sure List ALL of your current physicians: The safety of your Suboxone medication or prescription is your responsibility. Requests for replacement Suboxone will not be honored without an appointment. Do you understand that following the loss or theft of your prescription, it is at the discretion of our physician to determine whether you will be allowed to continue in this program? yes no I have completed this form truthfully and to the best of my ability. Signature Date 3
4 SUBOXONE NEW PATIENT INTRODUCTION Our clinic restricts our treatment panel to a limited number of pre-qualified patients. This program accepts only patients who are serious about overcoming opiate addiction. We do not assume general medical care of Suboxone patients. ALL patients must adhere to strict cash payment policies. This is a 13-month recovery program. To register please complete: STEP ONE Read the entire packet. Return completed forms to our office. You will be contacted by phone before acceptance. STEP TWO If accepted, our office will call to schedule your first appointment. Schedule first 3 appointments with prepayment of $350 by cash or credit card. STEP THREE Arrive IN WITHDRAWAL for first appointment of up to 3 hours. Be prepared for a urine drug screen. You will receive your prescription and you will be directed to the pharmacy to fill the prescription. Return with filled prescription to continue the initial visit. STEP FOUR Return for two follow up visits, the first 2-3 days after initial visit and the second 7-10 days after initial visit (included in the prepayment made in STEP TWO) At you 3 rd appointment, schedule a two-week follow up with prepayment of $85 cash or credit card Plan to schedule monthly maintenance visits thereafter. o Work/ school notes will be given as appropriate. Plan to attend 1 session of in-office mandatory Group Therapy and 2 AA meetings monthly. Duration of the treatment is individually determined by the patient, but will not exceed 13 months. If a visit is missed with no warning, if you are found to be using, or fail a urine drug screen, return to STEP ONE. You will be given a prescription for a 2-week taper dose, and you will be required to apply for re-acceptance into the program. Re-acceptance is not guaranteed. Prior missed appointment fee ($150) must be paid before reacceptance. 4
5 SUBOXONE PATIENT RESPONSIBILITIES I agree to store medication properly. Medication may be harmful to children, household members, guests, and pets. The pills should be stored in a safe place, out of the reach of children. If anyone besides the patients ingests the medication, the patient must call the Poison Control Center or 911 immediately. I agree to take the medication only as prescribed. The indicated dose should be taken daily, and the patient must not adjust the dose on his/her own. I agree to comply with the required pill counts and urine tests. Urine testing is a mandatory part of office maintenance; therefore, the patient must be prepared to give a urine sample for testing at each clinic visit. The patient should bring his or her medication to each appointment and may be asked to show the medication bottle for a pill count, including reserve medication. Patient may be asked to come in for random urine drug screens and/or pill counts and must comply within 24 hours of receiving notice. I agree to make and prepay for another appointment in case of a lost or stolen medication. I agree to notify the clinic in case of relapse to drug abuse. Relapse to opiate drug abuse can result in being removed from the Suboxone program. An appropriate treatment plan must be developed as soon as possible. The physician should be informed of a relapse before random urine testing reveals it. I agree to the guidelines of office operations. I understand the procedure for making appointments and paying for missed appointments and late cancellation fees. I have the phone number of this clinic and I understand the office hours. I understand that no medications will be prescribed by phone or on weekends. I understand that I am required to abide by these restraints in order to remain on the Suboxone treatment panel of this office. I understand that this treatment program does not provide medical or surgical care outside the scope of routine Suboxone maintenance. Signature Date 5
6 SUBOXONE TREATMENT FINANCIAL POLICIES Fees: $350- Includes Initial Three Visits and 12-Step Program Materials $85- Monthly Medication Management and Individual Counseling $25- MANDATORY Group Meetings once monthly Prepayment is required for all visits. We accept credit card, debit card, money order, or cash. NO CHECKS. The cost for the initial evaluation and Suboxone induction treatment is $350. This includes 3 visits (the initial visit along with 2 additional within 2-7 days). Additionally, direct access to private therapy, family therapy, a life coach, yoga, and meditation are provided for a small program fee. These services are provided to aid you in your recovery. There is a $150 cancellation fee (less than 24 hours notice) for the first visit. The cost for follow up appointments is $85. Follow up appointments are scheduled every 2-4 weeks. Urine drug screening may be done as frequently as every visit. The cost of drug screening in our office is $55 for a full panel or $15 for a Suboxone-only panel. Payment for all prior visits must remain current in order to retain your reservation on the panel. We do not wish you to undergo sudden withdrawal from Suboxone. This will be the result if you fail to reserve and keep your appointments. There is an $85 cancellation fee (less than 24 hours notice) for follow up appointments. Your reservation in our limited program is secured with a paid up account. At the conclusion of your visit you will be asked to reserve your next visit. You may be required to go to the medical lab at the end of the first office visit for blood and urine samples, metabolic profiles, HIV, and drug screening. Additional tests may be required as indicated by history and examination. Payment will be expected at the time of service. Future charges for lab tests may be billable by the lab to the patient. Please fill in your credit card information below. This information will be used by our office for the first visit payment and future payments after your acceptance. Credit Card Information Type: MasterCard Visa Discover Credit Card No.: Expiration Date: / Security Code: (3 or 4 digit # on card) Signature: Print Name: (Your signature authorizes Compass Recovery to process your credit card for any charges incurred.) 6
7 SUBOXONE TREATMENT INFORMED CONSENT Suboxone (buprenorphine + naloxone) is an FDA approved medication for treatment of opiate (narcotic) dependence. It can be used for detoxification or for maintenance therapy. It can cause withdrawal reactions from standard narcotics or Methadone while at the same time having a mild narcotic pain relieving effect from the Suboxone. The use of Suboxone can result in physical dependence of the buprenorphine, but withdrawal is much milder and slower than with heroin or Methadone. If Suboxone is suddenly discontinued, patients will have only mild symptoms such as muscle aches, stomach cramps, or diarrhea lasting several days. To minimize the possibility of opiate withdrawal, Suboxone may be discontinued gradually, usually over several weeks or more. Because of its narcotic-reversing effect, if you are dependent on opiates, you should be in as much withdrawal as possible when you take the first dose of Suboxone. You must be off Methadone for at least 24 hours (after tapering yourself down to at least 40mg per day) or off of other narcotics for at least 12 hours and showing signs of withdrawal before starting Suboxone. Some patients find that it takes several days for the transition to Suboxone from the opiate they had been using. After stabilized on Suboxone, other opiates will have virtually no effect. Attempts at more opiates could result in an opiate overdose. Do not take any other medication without discussing it with your physician. Combining Suboxone with alcohol or some other medications may also be hazardous. We do not prescribe, under any circumstances, narcotics, Methadone, or sedatives for patients desiring maintenance or detoxification from narcotics. All Suboxone must be purchased at pharmacies. We will not supply any Suboxone. Signature Date 7
8 SUBOXONE TREATMENT FOLLOW UP APPOINTMENTS Follow up appointments will be at least monthly. The visits are focused on evaluating compliance and the possibility of relapse. They may include: Film/Pill counts Urine testing for drug abuse An interim history of any new medical problems or social stressors 12 Step Program discussion Prescription of medication No refills of Suboxone will be made for any reason except during a clinic visit. Appointments do not include evaluation or care for other problems Dangerous behavior, relapse and relapse prevention. The following behavior red flags will be addressed with the patient as soon as they are noticed: Missing appointments Running out of medication too soon Taking medication off schedule Refusing urine testing Neglecting to mention new medication or outside treatment Agitated behavior Frequent or urgent inappropriate phone calls Outbursts of anger Lost or stolen medication Non-payment of visits as agreed, missed appointments or cancellations within 24 hours of your appointment Treatment may be discontinued if these behaviors occur SUBOXONE TREATMENT MAINTENANCE Suboxone treatment may be discontinued for several reasons: If you are unable to stop your dependence, or if you continue to feel like using narcotics, even at the top doses of Suboxone, the doctor will discontinue treatment with Suboxone and you will be required to seek help elsewhere. If you do not abide by our agreements you may be discharged from the Suboxone treatment program. Prompt payment of clinic fees is part of this program. If your account does not remain current, appointments cannot be scheduled. If appointments cannot be kept as agreed, your status as an active patient will be cancelled. In the case of an allergic reaction to medication, Suboxone must be discontinued. Dangerous or inappropriate behavior will result in your discharge from the Suboxone treatment. o In the case of dangerous behavior there will be no two-week taper. You will be discharged and asked not to return. Not attending mandatory group and/or mandatory 2 AA meetings. 8
9 THERAPY REQUIREMENTS Group therapy will be held in the lobby of Prince Ave Primary Care from 6:30-7:30 every Tuesday and Wednesday. You will be required to attend at least 1 group therapy session each month. You will sign up at your monthly appointment. Group therapy will include 12 Step Principles, and learning other life skills and coping mechanisms to aid in your recovery. Through the process of sharing your recovery and abstinence, you will strengthen your pursuit of recovery. Group success depends on consistent attendance and dedication from every individual. This should be a place of compassion of surrender. You will be required to attend at least 2 AA meetings monthly and obtain the signature of the meetings leader. CERTIFICATES The sixth month and the twelfth month of sobriety Dr. Gibson will award you with a certificate of congratulations. This reward process is important so that you are able to recognize your significant growth. 9
10 SUBOXONE MATERIALS CONFIRMATION INITIAL BELOW: Questionnaire New Patient Introduction Patient Responsibilities Financial Policy Follow Up Protocols Maintenance Informed Consent Therapy Certificates My signature below and initials by the name of each individually listed document, certifies that I fully understand and agree to the contents of each document. Signature Printed name Date FOR OFFICE USE ONLY INITIAL VISIT DATE: SECOND VISIT DATE: THIRD VISIT DATE: ADDITIONAL VISIT DATES: URINE DRUG SCREEN DATES: GROUP THERAPY MEETING DATES: AA MEETING DATES: 10
SUBOXONE FILM NEW PATIENT INTRODUCTION
SUBOXONE FILM NEW PATIENT INTRODUCTION Our clinic restricts our treatment panel to a limited number of pre-qualified patients. This program accepts only patients who are serious about overcoming opiate
More informationPatient Agreement for the use of Opioid Medications
today s date Patient Name date of birth Patient Agreement for the use of Opioid Medications The purpose of this agreement is to give you information about the medications that may be part of your treatment
More informationPATIENT INTAKE: MEDICAL HISTORY. Name. Address. Phone (W) (H) (C) DOB Age SS# Emergency Contact. Relationship to patient Phone
PATIENT INTAKE: MEDICAL HISTORY Name Address Phone (W) (H) (C) DOB Age SS# Emergency Contact Relationship to patient Phone Primary care physician Phone Have you ever had an EKG? Y N Date Current or past
More informationAhsan U. Rashid, M.D., F.A.C.P.
Ahsan U. Rashid, M.D., F.A.C.P. OPIOID MAINTENANCE AND CONSENT Instructions: Review this document before signing. This document will help both the patient and caregivers in establishing a medical program
More informationControlled Substance and Wellness Agreement
Controlled Substance and Wellness Agreement You and your provider have agreed on the use of controlled substance medications to treat your: We want to make sure you know how to manage your new prescription(s)
More informationFor female patients only: To the best of my knowledgei am NOT pregnant. Patients Initials:
Which doctor are you here to see? NAME OF PATIENT: DATE: TO THE PATIENT: As a patient, you have the right to be informed about your condition and the recommended medical or diagnostic procedure or drug
More informationPATIENT HISTORY DATA FORM Psychiatric, Health and Wellness, LLC 810 Michael Drive, Suite L Chesterton, IN NAME
PATIENT HISTORY DATA FORM Psychiatric, Health and Wellness, LLC 810 Michael Drive, Suite L Chesterton, IN 46304 PRINT THIS FORM, COMPLETE AND BRING WITH YOU (DO NOT COMPLETE ONLINE) : NAME: LAST FIRST
More informationPrepublication Requirements
Issued Prepublication Requirements The Joint Commission has approved the following revisions for prepublication. While revised requirements are published in the semiannual updates to the print manuals
More informationApplicant s Name (PRINT): Applicant s Signature: Date: Anticipated Admission Date: Time: Staff Approval: Date:
FREEDOM SUBSTANCE ABUSE TREATMENT APPLICATION/REQUIREMENTS for ADMISSION PURPOSE: Our primary goal is to facilitate a stable environment that gives individuals an opportunity to break the cycle of homelessness
More informationPatient Information Form
Patient Information Form Patient Name: (Last) (First) (MI) Name you prefer to be called: Mailing address: City: State: Zip: Best daytime phone: May we leave a message there? Yes No Alternate phone number:
More informationSUBOXONE Film, SUBOXONE Tablets, and SUBUTEX Tablets. Risk Evaluation and Mitigation Strategy (REMS) Program
SUBOXONE Film, SUBOXONE Tablets, and SUBUTEX Tablets Risk Evaluation and Mitigation Strategy (REMS) Program Office-Based Buprenorphine Therapy for Opioid Dependence: Important Information for Prescribers
More informationOPIOID PAIN MEDICATION Agreement and Informed Consent
OPIOID PAIN MEDICATION Agreement and Informed Consent I. Introduction Research and clinical experience show that opioid (narcotic) pain medications are helpful for some patients with chronic pain. The
More informationINFORMED CONSENT FOR OPIOID TREATMENT FOR NON-CANCER/CANCER PAIN Texas Pain and Regenerative Medicine
INFORMED CONSENT FOR OPIOID TREATMENT FOR NON-CANCER/CANCER PAIN Texas Pain and Regenerative Medicine The purpose of this agreement is to give you information about the medications you will be taking for
More informationWELCOME TO OUR PRACTICE
979 E. Third ST, STE A-240 Chattanooga, TN 37403 Phone- (423) 243-3342 Fax- (423) 648-6487 WELCOME TO OUR PRACTICE I wanted to thank you for choosing ReNu Chattanooga. I pledge to you that my staff and
More informationBuprenorphine: An Introduction. Sharon Stancliff, MD Harm Reduction Coalition September 2008
Buprenorphine: An Introduction Sharon Stancliff, MD Harm Reduction Coalition September 2008 Objective Participants will be able to: Discuss the role of opioid maintenance in reducing morbidity and mortality
More informationMEDICATION MANAGEMENT AGREEMENT
MEDICATION MANAGEMENT AGREEMENT The goal of this agreement is to ensure that you and your physician comply with all state and federal regulations concerning the prescribing of controlled substances. The
More informationD. Janene Holladay, M.D. Board Certifications: American Board of Anesthesiology American Board of Pain Medicine American Board of Addiction Medicine
D. Janene Holladay, M.D. Board Certifications: American Board of Anesthesiology American Board of Pain Medicine American Board of Addiction Medicine Financial Disclosure I have no relevant financial relationships
More informationNew Patient Information
New Patient Information First Name: Last Name: M.I.: Address: City: State: Zip Code: Mobile Phone: Home Phone: Email: Preferred method of communication: Mobile Phone Home Phone Email Date of Birth: Age:
More informationPATIENT SIGNATURE: DOB: Date:
CINCINNATI PAIN PHYSICIANS, LLC (CPP) ACKNOWLEDGEMENT OF RECEIPT OF NOTICE OF PRIVACY PRACTICES By signing below, I acknowledge that I have received a copy of CPP s Notice of Privacy Practices. The Notice
More informationAccess Endodontics Marat Tselnik, DDS -PRACTICE LIMITED TO ENDODONTICS-
Access Endodontics Marat Tselnik, DDS -PRACTICE LIMITED TO ENDODONTICS- REFERRED BY: TODAY S DATE: PATIENT NAME HOME PHONE (LAST) (FIRST) (MIDDLE) E-MAIL CELL PHONE HOME ADDRESS (STREET) (CITY) (STATE)
More informationBuprenorphine & Controlled Substance Treatment Agreement
Buprenorphine & Controlled Substance Treatment Agreement I agree to accept the following treatment contract for buprenorphine office-based opioid addiction treatment: 1. I will keep my medication in a
More informationWilson C, Fagan E. Providing office-based treatment of opioid use disorder. Ann Fam Med. 2017;15(5):481.
Supplemental material for Wilson C, Fagan E. Providing office-based treatment of opioid use disorder. Ann Fam Med. 2017;15(5):481. Courtenay Gilmore Wilson, PharmD 1,2 E. Blake Fagan, MD 1,3 1 Mountain
More informationAPPLICATION FOR ADMISSION (PLEASE PRINT CLEARLY)
1317 w. Washington Blvd. Fort Wayne, In. 46802 260-424-2341 APPLICATION FOR ADMISSION (PLEASE PRINT CLEARLY) NAME: _ FIRST MI LAST DATE OF BIRTH: / / AGE: SOCIAL SECURITY NUMBER: LAST OR CURRENT ADDRESS:
More informationLouisiana. Prescribing and Dispensing Profile. Research current through November 2015.
Prescribing and Dispensing Profile Louisiana Research current through November 2015. This project was supported by Grant No. G1599ONDCP03A, awarded by the Office of National Drug Control Policy. Points
More informationMEDICATION ASSISTED TREATMENT
MEDICATION ASSISTED TREATMENT MODULE 14 ALLIED TRADES ASSISTANCE PROGRAM PREVENTATIVE EDUCATION: SUBSTANCE USE DISORDER Medication Assisted Treatment Types of Medication Assisted Treatment: Methadone Naltrexone
More informationTuscarawas County Health Department. Vivitrol Treatment Consent
Tuscarawas County Health Department Vivitrol Treatment Consent I. Vivitrol Medication Guide: a. VIVITROL (viv-i-trol) (naltrexone for extended-release injectable suspension) b. Read this Medication Guide
More informationUpdated: 08/2017 DMMA Approved: 11/2017
Request for Prior Authorization for Therapy to Treat Binge Eating Disorder Website Form www.highmarkhealthoptions.com Submit request via: Fax - 1-855-476-4158 All requests for medications to treat Binge
More informationMethadone Treatment. in federal prison
INFORMATION FOR FEDERAL PRISONERS IN BRITISH COLUMBIA Methadone Treatment in federal prison This booklet will explain how to qualify for Methadone treatment in prison, the requirements of the Correctional
More informationAddiction is overwhelming. Recovery doesn t have to be.
Welcome Addiction is overwhelming. Recovery doesn t have to be. You are in the right place. At Angels of America, our purpose is to deliver the best individualized comprehensive outpatient treatment for
More informationInterdisciplinary Management of Opioid Use Disorder in Rural Primary Care Settings
Interdisciplinary Management of Opioid Use Disorder in Rural Primary Care Settings BRIAN GARVEY, MD, MPH REBECCA CANTONE, MD OREGON HEALTH & SCIENCE UNIVERSITY SCAPPOOSE RURAL HEALTH CENTER Disclosures
More informationAppendix F Federation of State Medical Boards
Appendix F Federation of State Medical Boards Model Policy Guidelines for Opioid Addiction Treatment in the Medical Office SECTION I: PREAMBLE The (name of board) recognizes that the prevalence of addiction
More informationMethadone Treatment. in federal prison
INFORMATION FOR FEDERAL PRISONERS IN BRITISH COLUMBIA Methadone Treatment in federal prison This booklet will explain how to qualify for Methadone treatment in prison, the requirements of the Correctional
More informationNew Client Reformer Session Packet
New Client Reformer Session Packet Welcome and thank you for your interest in the Pilates Reformer program with University Recreation. You are taking the first steps towards improved health and wellness.
More informationFY17 SCOPE OF WORK TEMPLATE. Name of Program/Services: Medication-Assisted Treatment: Buprenorphine
FY17 SCOPE OF WORK TEMPLATE Name of Program/Services: Medication-Assisted Treatment: Buprenorphine Procedure Code: Modification of 99212, 99213 and 99214: 99212 22 99213 22 99214 22 Definitions: Buprenorphine
More informationSubstance Abuse Level of Care Criteria
Substance Abuse Level of Care Criteria Table of Contents SUBSTANCE ABUSE OUTPATIENT: Adolescent... 3 SUBSTANCE ABUSE PREVENTION: Adult... 7 OPIOID MAINTENANCE THERAPY: Adult... 8 SUBSTANCE ABUSE INTERVENTION:
More informationMedication-Assisted Treatment. What Is It and Why Do We Use It?
Medication-Assisted Treatment What Is It and Why Do We Use It? What is addiction, really? o The four C s of addiction: Craving. Loss of Control of amount or frequency of use. Compulsion to use. Use despite
More informationMEDICATION MANAGEMENT AGREEMENT Pain Management Program Participation Agreement and Consent
MEDICATION MANAGEMENT AGREEMENT Pain Management Program Participation Agreement and Consent Pain may be effectively managed through the use of controlled substance medications (referred to below as opioids
More informationOklahoma. Prescribing and Dispensing Profile. Research current through November 2015.
Prescribing and Dispensing Profile Oklahoma Research current through November 2015. This project was supported by Grant No. G1599ONDCP03A, awarded by the Office of National Drug Control Policy. Points
More informationUtah. Prescribing and Dispensing Profile. Research current through November 2015.
Prescribing and Dispensing Profile Utah Research current through November 2015. This project was supported by Grant No. G1599ONDCP03A, awarded by the Office of National Drug Control Policy. Points of view
More informationVivitrol Drug Court and Medication Assisted Treatment
Vivitrol Drug Court and Medication Assisted Treatment Amy Black, CNP and Judge Fred Moses Court program Self-starters Mission Statement To provide court-managed, medically assisted drug intervention treatment
More informationThe CARA & Buprenorphine Prescribing for APNs & PAs
The CARA & Buprenorphine Prescribing for APNs & PAs William J. Lorman, JD, PhD, MSN, PMHNP-BC, CARN-AP FIAAN Assistant Clinical Professor, Drexel University, Philadelphia, PA V. P. & Chief Clinical Officer,
More informationAPPLICATION FOR SERVICES
APPLICATION FOR SERVICES CLIENT - PERSONAL INFORMATION First Name M.I. Last Name Today s Street Address City State Zip Birth date Home phone (ok to leave msg? Y - N) Cell phone (ok to leave msg? Y - N
More informationPATIENT TREATMENT CONTRACT
Bridger Psychiatric Services, P.C. 2040 N. 22 nd Avenue, Ste. 2 Bozeman, MT 59718 406-586-5511 * 406-586-4713 (fax) PATIENT TREATMENT CONTRACT Patient Name Date As a participant in buprenorphine treatment
More informationANSWER: There are 18 medicine drop box locations in Lehigh County and 23 medicine drop box locations in Northampton County.
Questions from the Lehigh Valley Summit on Addiction and Recovery 1. Where can used needles be dropped off? Not just from illegal drug use but also from diabetic use? ANSWER: The DEP recommends that people
More informationTalking with your doctor
SUBOXONE (buprenorphine and naloxone) Sublingual Film (CIII) Talking with your doctor Opioid dependence can be treated. Talking with your healthcare team keeps them aware of your situation so they may
More informationCalifornia. Prescribing and Dispensing Profile. Research current through November 2015.
Prescribing and Dispensing Profile California Research current through November 2015. This project was supported by Grant No. G1599ONDCP03A, awarded by the Office of National Drug Control Policy. Points
More informationTop of the World Ranch Treatment Centre Admissions Information Record Demographics
1 Client Name: Top of the World Ranch Treatment Centre Admissions Information Record Demographics : of Birth: Health Card #: Gender: Male Female Phone #: May we leave a message? Street Address: Email Address:
More informationPatient and Family Agreement on Opioids
Patient and Family Agreement on Opioids We care about our patients and are committed to their recovery and wellness. We offer our patients medications and options for various services to keep them from
More informationRhode Island. Prescribing and Dispensing Profile. Research current through November 2015.
Prescribing and Dispensing Profile Rhode Island Research current through November 2015. This project was supported by Grant No. G1599ONDCP03A, awarded by the Office of National Drug Control Policy. Points
More informationSANTA BARBARA COUNTY DEPARTMENT OF Behavioral Wellness A System of Care and Recovery
Page 1 of 9 SANTA BARBARA COUNTY DEPARTMENT OF Behavioral Wellness A System of Care and Recovery Departmental Polley and Procedure Section Sub-section Alcohol and Drug Program (ADP) Effective: 7/11/2018
More informationMethadone Maintenance 101
Methadone Maintenance 101 OTP/DAILY DOSING CLINICS - ANDREW PUTNEY MD Conflicts of Interest - Employed by Acadia HealthCare 1 Why Methadone? At adequate doses methadone decreases opioid withdrawal symptoms
More informationDavid Palmieri, D.M.D., M.S., LTD., Frank R. Portell D.M.D.,M.S. & Nathan Schoenly, D.D.S. Please Check: Mr. Ms. Mrs. Dr. Fr. Sr. Hon.
David Palmieri, D.M.D., M.S., LTD., Frank R. Portell D.M.D.,M.S. & Nathan Schoenly, D.D.S. PATIENT REGISTRATION Please Check: Mr. Ms. Mrs. Dr. Fr. Sr. Hon. OTHER: Your Name (first name) (middle int.) (last
More information(Adapted with permission from the D-H Knowledge Map Primary Care Buprenorphine Guidelines)
Buprenorphine Initiation and Maintenance in Pregnancy (Adapted with permission from the D-H Knowledge Map Primary Care Buprenorphine Guidelines) Assessment The diagnosis of OUD should be confirmed by DSM-5
More information*IN10 BIOPSYCHOSOCIAL ASSESSMENT*
BIOPSYCHOSOCIAL ASSESSMENT 224-008B page 1 of 5 / 06-14 Please complete this questionnaire and give it to your counselor on your first visit. This information will help your clinician gain an understanding
More informationTop of the World Ranch Treatment Centre Admissions Information Record Demographics
1 Client Name: Date of Birth: Top of the World Ranch Treatment Centre Admissions Information Record Demographics Alias or AKA : Date: Gender: Male Female Phone #: May we leave a message? Street Address:
More informationPrescription Drug Safety for Teens
Prescription Drug Safety for Teens Curriculum Guide Recommended Grade Level 9-12 Total Time 30-45 minutes Subject Fit Health Standards Alignment National Health Education Standards (NHES) With prescription
More informationFighting Today s Opioid Epidemic
Fighting Today s Opioid Epidemic Establish in 1966 as a Public Health Department Location: Rock Falls, IL/Whiteside County Population: Whiteside County 2015--57,079 Serving Rural IL: Primarily Whiteside,
More informationMethadone/ Suboxone Treatment in federal prison
INFORMATION FOR FEDERAL PRISONERS IN BRITISH COLUMBIA Methadone/ Suboxone Treatment in federal prison This booklet will explain how to qualify for Opioid Substitution Therapy (OST) in prison, how it is
More informationProgram Application. Name: SSN: Address: City: State: Zip: Phone: Date of Birth: Age: Occupation: Highest Grade Completed/College/Degree:
DATE: I. PERSONAL INFORMATION Name: SSN: Address: City: State: Zip: Phone: Date of Birth: Age: Occupation: Highest Grade Completed/College/Degree: Other skills/training: What tools can you use: Farm or
More informationEffective Date: May 19, Revised Date: August 18, Policy Number: MED Policy 313. Pain Management Long Term Opioid Use
Effective Date: May 19, 2008 Revised Date: August 18, 2015 Approved by: Thomas M Tocher, MD, MPH, Chief Clinical Officer Policy Number: MED Policy 313 Title: Pain Management Long Term Opioid Use POLICY
More informationAN INTRODUCTION TO THE TREATMENT OF OPIOID USE DISORDERS IN PRIMARY CARE
AN INTRODUCTION TO THE TREATMENT OF OPIOID USE DISORDERS IN PRIMARY CARE Valerie Carrejo, MD Assistant Professor UNM Family Medicine Advances in Primary Care April 14, 2017 Objectives Review the basic
More informationTennessee. Prescribing and Dispensing Profile. Research current through November 2015.
Prescribing and Dispensing Profile Tennessee Research current through November 2015. This project was supported by Grant No. G1599ONDCP03A, awarded by the Office of National Drug Control Policy. Points
More informationSUBOXONE TREATMENT PROGRAM
SUBOXONE TREATMENT PROGRAM What is Suboxone? Suboxone is a medication used for the treatment of addiction to prescription pain medication, heroin addiction, methadone or other opioid dependence. The primary
More informationSUBOXONE INSTRUCTIONS FOR INITIAL APPOINTMENT
Retain This Form SUBOXONE INSTRUCTIONS FOR INITIAL APPOINTMENT 1. Arrive early to complete paperwork. 2. Bring all pill bottles. 3. Bring valid photo ID. 4. Bring insurance card if insured. 5. 6. The initial
More informationCONTROLLED SUBSTANCE (NARCOTIC) AGREEMENT
CONTROLLED SUBSTANCE (NARCOTIC) AGREEMENT The purpose of this consent form is to protect your access to controlled substances and to protect our ability to prescribe for you. The long- term use of substances
More informationAddress (if different from above):
Lee H. Baker, DDS 1243 Augusta West Pkwy Augusta, GA 30909 (706) 855-8989-Phone (706) 855-0321-Fax www.drleebaker.com Welcome to our practice! In order to know you and your child better, please complete
More informationIf you do not have health insurance, the initial appointment will be $232. Follow-up appointments will be $104.
APPLICATION FOR ADMISSION TO ADDICTION MEDICINE PROGRAM AT MARQUETTE GENERAL BEHAVIORAL HEALTH SERVICES FOR BUPRENORPHINE (Suboxone) THERAPY In order to be considered for admission to the Addiction Medicine
More informationMEDICATION GUIDE SUBOXONE (Sub OX own) (buprenorphine and naloxone) Sublingual Tablets (CIII)
MEDICATION GUIDE SUBOXONE (Sub OX own) (buprenorphine and naloxone) Sublingual Tablets (CIII) IMPORTANT: Keep SUBOXONE in a secure place away from children. Accidental use by a child is a medical emergency
More informationBrief History of Methadone Maintenance Treatment
METHADONE Brief History of Methadone Maintenance Treatment Methadone maintenance treatment was on the cusp of the social revolution in the sixties. Doctors and public health workers had concluded what
More informationIn 2008, an estimated 282,000 persons
National Survey of Substance Abuse Treatment Services The N-SSATS Report January 28, 2010 Similarities and Differences in Opioid Treatment Programs that Provide Methadone Maintenance or Buprenorphine Maintenance
More informationPrescription Monitoring Program (PMP)
06/15/2018 FACT SHEET Implementation of Enacted Prescribing Limits and Requirements and Relevant Opioid Prescribing Laws and Rules Background: The 2016 law (Chapter 488) makes five major changes to opioid
More informationOpioid Dependence and Buprenorphine Management
Opioid Dependence and Buprenorphine Management Kevin Kapila, MD Fenway Health Medical Director of Behavioral Health Instructor in Medicine Harvard Medical School Learning Objectives Understand the rationale
More informationName: Gender: male female Age: Date of birth: / / Preferred phone: cell home work other. Alternate phone: cell home work other.
Casey Alexander Paleos, MD NEW CLIENT INTAKE FORM 775 Park Avenue, Suite 200-2 Huntington, NY 11743 tel 631-629-5887 Date: / / BASIC INFORMATION Name: Gender: male female Age: Date of birth: / / Preferred
More informationSober Housing Guidelines/Agreement
Sober Housing Guidelines/Agreement Welcome to PV Sober Housing. Your recovery process is important and sobriety remains a primary goal. Ultimately your recovery is your responsibility, but the PV sober
More informationUnderstanding Medication in Addiction Treatment for Drug Court Participants
Understanding Medication in Addiction Treatment for Drug Court Participants Introduction This pocket guide is for drug court participants who may be prescribed or considering medication as a part of addiction
More informationOUTPATIENT SERVICES PSYCHOLOGICAL SERVICES CONTRACT
OUTPATIENT SERVICES PSYCHOLOGICAL SERVICES CONTRACT (This is a detailed document. Please feel free to read at your leisure and discuss with Dr. Gard in subsequent sessions. It is a document to review over
More informationADULT INTAKE QUESTIONNAIRE. Ok to leave message? Yes No. Present psychological difficulties please check any that apply to you at this time.
ADULT INTAKE QUESTIONNAIRE Name: Today s Date: Age: Date of Birth: Address: Home phone: Work phone: Cell phone: Ok to leave message? Yes No Ok to leave message? Yes No Ok to leave message? Yes No Email:
More informationthe facts about BUPRENORPHINE for Treatment of Opioid Addiction
the facts about BUPRENORPHINE for Treatment of Opioid Addiction i I d been shot on the streets, I d been in detox. It was jails, institutions. Death, I knew, was imminent for me so I started my recovery
More informationInformation and Consent for Administration of Immunotherapy (Allergy Injections)
Information and Consent for Administration of Immunotherapy (Allergy Injections) PLEASE READ AND BE CERTAIN THAT YOU UNDERSTAND THE FOLLOWING INFORMATION PRIOR TO SIGNING THIS CONSENT FOR TREATMENT PURPOSE
More informationVirginia. Prescribing and Dispensing Profile. Research current through November 2015.
Prescribing and Dispensing Profile Virginia Research current through November 2015. This project was supported by Grant No. G1599ONDCP03A, awarded by the Office of National Drug Control Policy. Points
More informationTransitional House Application
St. Joseph Lily House Transitional House Application Date: Legal Name: Date of birth: Social Security #: Driver s License/CA ID # Telephone #: Message Phone#: Are you currently Married Divorced Single
More informationBuprenorphine treatment
South London and Maudsley NHS Foundation Trust Buprenorphine treatment Information for service users Page Buprenorphine treatment What is buprenorphine? Buprenorphine (trade name Subutex ) is an opioid
More information201 KAR 9:270. Professional standards for prescribing or dispensing Buprenorphine-Mono-Product or Buprenorphine-Combined-with-Naloxone.
201 KAR 9:270. Professional standards for prescribing or dispensing Buprenorphine-Mono-Product or Buprenorphine-Combined-with-Naloxone. RELATES TO: KRS 311.530-311.620, 311.990 STATUTORY AUTHORITY: KRS
More informationOpioid dependence and buprenorphine treatment
Opioid dependence and buprenorphine treatment David Roll, MD Revere Family Health, Cambridge Health Alliance Instructor in Medicine, Harvard Medical School Joji Suzuki MD Medical Director of Addictions
More informationPersonal Training Registration Packet
Registration Packet Client name: Sessions Purchased: 3 Sessions 30 Minutes 60 Minutes 5 Sessions 10 Sessions 15 Sessions Purchase Date: General and Healthy History Questionnaire Name: Penn ID: Date of
More informationSuboxone, Zubsolv, Bunavail (buprenorphine with naloxone sublingual tablets and film), Buprenorphine sublingual tablets
Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.70.32 Subject: Suboxone Drug Class Page: 1 of 7 Last Review Date: June 24, 2016 Suboxone Drug Class Description
More informationVermont. Prescribing and Dispensing Profile. Research current through November 2015.
Prescribing and Dispensing Profile Vermont Research current through November 2015. This project was supported by Grant No. G1599ONDCP03A, awarded by the Office of National Drug Control Policy. Points of
More informationPreferred Name (s): Local Address: City: State: Zip: Permanent Address: City: State: Zip: Years of Education: Occupation: Gender: M F
Today Date: Client Name(s) : Psychological Consultants Northgate Center 1210 ½ -7 th Street NW, Suite 216 Rochester, MN 55901 www.psychologicalconsultants1.com Office: (507) 252-9292 Fax: (507) 252-9203
More informationTracker e-prescribing 101. The Complete Guide
Tracker e-prescribing 101. The Complete Guide Copyright Stratum Access Technologies, Inc. 2017 www.stratumaccess.com Electronic prescribing, known in short as e-prescribing, is a method of prescription
More informationBaby-Sitting - $20 Per Day/Per Nanny (local clients) Less than 24 hours notice $30 Per Day/Per Nanny. Hotel Overnight Sitting - $35 per Day/Per Nanny
ALL ABOUT NANNIES BUSINESS PHONE: 602-266-9116 BUSINESS FACSIMILE: 602-266-9787 BUSINESS EMAIL: ADMIN@ALLABOUTNANNIESINC.COM TEMPORARY, BABY-SITTING, HOTEL & ON-CALL AS NEEDED Mother s Full Name: Place
More informationThe science of the mind: investigating mental health Treating addiction
The science of the mind: investigating mental health Treating addiction : is a Consultant Addiction Psychiatrist. She works in a drug and alcohol clinic which treats clients from an area of London with
More informationClinical Guidelines for the Pharmacologic Treatment of Opioid Use Disorder
Clinical Guidelines for the Pharmacologic Treatment of Community Behavioral Health (CBH) is committed to working with our provider partners to continuously improve the quality of behavioral healthcare
More informationDRUG COURT PARTICIPANT HANDBOOK NAVAJO COUNTY SUPERIOR COURT HOLBROOK, ARIZONA
DRUG COURT PARTICIPANT HANDBOOK NAVAJO COUNTY SUPERIOR COURT HOLBROOK, ARIZONA Revised June 2012 1. PROGRAM DESCRIPTION Drug Court is a court-managed drug intervention and treatment program. It may be
More informationFREQUENTLY ASKED QUESTIONS PATIENTS SUBOXONE (buprenorphine HCl/naloxone HCl dihydrate) sublingual tablet
463142 State Road 200, Yulee, Florida 32097 Phone: 904-225-8280 Fax: 904-225-8232 FREQUENTLY ASKED QUESTIONS PATIENTS SUBOXONE (buprenorphine HCl/naloxone HCl dihydrate) sublingual tablet 1. Why do I have
More informationREGISTRATION FORM. PATIENT INFORMATION Información del paciente. Patient s last name (Apellido) : First(Nombre): Middle (Segundo nombre): Mr. Mrs.
REGISTRATION FORM PATIENT INFORMATION Información del paciente Patient s last name (Apellido) : First(Nombre): Middle (Segundo nombre): Mr. Mrs. Miss Ms. Birth date (Fecha de nacimiento) : / / Age (Edad):
More informationMinnesota. Prescribing and Dispensing Profile. Research current through November 2015.
Prescribing and Dispensing Profile Minnesota Research current through November 2015. This project was supported by Grant No. G1599ONDCP03A, awarded by the Office of National Drug Control Policy. Points
More informationLake Psychological Services, LLC
Lake Psychological Services, LLC Welcome to Lake Psychological Services and thanks for choosing our office for your health care needs. Seeking treatment is not an easy decision and you may have questions
More informationSTATE OF NEW JERSEY DEPARTMENT OF CORRECTIONS. Medication Assisted Treatment For Substance Use Disorder In the New Jersey County Jails
STATE OF NEW JERSEY DEPARTMENT OF CORRECTIONS Medication Assisted Treatment For Substance Use Disorder In the New Jersey County Jails NOTICE OF GRANT OPPORTUNITY (Updated) Announcement Date: September
More informationADVANCED BEHAVIORAL HEALTH, INC. Clinical Level of Care Guidelines
The Clinical Level of Care Guidelines contained on the following pages have been developed as a guide to assist care managers, physicians and providers in making medical necessity decisions about the least
More information9/9/2016. Drug Name (select from list of drugs shown) Bunavail Buccal Film (buprenorphinenaloxone) Suboxone Sublingual Film (buprenorphine-naloxone)
9/9/2016 Prior Authorization Form PASSPORT HEALTH PLAN KENTUCKY MEDICAID Buprenorphine Products This fax machine is located in a secure location as required by HIPAA regulations. Complete/review information,
More information